Concepedia

Rick Oerlemans

RO

Statistics

Publications

8

Citations

274

H-Index

8

Active since

2017

Affiliations

University of Groningen(Current)

University Medical Center Groningen

University of Pittsburgh

Rick Oerlemans is an author at University of Groningen specializing in drug discovery, pharmacy, and life sciences.

Publications per year

2017–2023

8

Publications

8

Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics

Rick Oerlemans, Angel J. Ruiz‐Moreno, Yingying Cong et al. · RSC Medicinal Chemistry · 2020 · 84 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Hypericin Inhibit Alpha-Coronavirus Replication by Targeting 3CL Protease

Yue Zhang, Huijie Chen, Mengmeng Zou et al. · Viruses · 2021 · 41 citations · Full text

Life Sciences, Infectious Diseases, Medicinal Chemistry +17

Combining High‐Throughput Synthesis and High‐Throughput Protein Crystallography for Accelerated Hit Identification

Fandi Sutanto, Shabnam Shaabani, Rick Oerlemans et al. · Angewandte Chemie International Edition · 2021 · 37 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +13

Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells

Mikhail S. Chesnokov, Marianna Halasi, Soheila Borhani et al. · Cell Death and Disease · 2021 · 32 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Engineering a Plant Polyketide Synthase for the Biosynthesis of Methylated Flavonoids

Bo Peng, Lili Zhang, Siqi He et al. · Journal of Agricultural and Food Chemistry · 2023 · 26 citations · Full text

Engineering, Bioengineering, Biotechnology +17

1–5 of 8